Medical Care
Global CD74 Antibody Market Research Report 2025
- May 12, 25
- ID: 236051
- Pages: 110
- Figures: 108
- Views: 9
The global market for CD74 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CD74 Antibody (LN-2) is an IgG1 κ mouse monoclonal CD74 antibody (also designated HLA class II histocompatibility antigen gamma chain antibody) that detects the CD74 protein of mouse, rat and human origin by WB, IP, IF, IHC(P) and FCM.
North American market for CD74 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD74 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CD74 Antibody in Immunochemistry (IHC) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CD74 Antibody include Merck, Bioss, BosterBio, QED Bioscience, Novus Biologicals, GeneTex, RayBiotech, LifeSpan BioSciences, EpiGentek, Leading Biology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD74 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD74 Antibody.
The CD74 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD74 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD74 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Bioss
BosterBio
QED Bioscience
Novus Biologicals
GeneTex
RayBiotech
LifeSpan BioSciences
EpiGentek
Leading Biology
ProSci
NSJ Bioreagents
OriGene Technologies
BioLegend
Bethyl Laboratories
ABclonal Technology
AssayPro
Miltenyi Biotec
Antigenix America Inc.
G Biosciences
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD74 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CD74 Antibody (LN-2) is an IgG1 κ mouse monoclonal CD74 antibody (also designated HLA class II histocompatibility antigen gamma chain antibody) that detects the CD74 protein of mouse, rat and human origin by WB, IP, IF, IHC(P) and FCM.
North American market for CD74 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD74 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CD74 Antibody in Immunochemistry (IHC) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CD74 Antibody include Merck, Bioss, BosterBio, QED Bioscience, Novus Biologicals, GeneTex, RayBiotech, LifeSpan BioSciences, EpiGentek, Leading Biology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD74 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD74 Antibody.
The CD74 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD74 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD74 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Bioss
BosterBio
QED Bioscience
Novus Biologicals
GeneTex
RayBiotech
LifeSpan BioSciences
EpiGentek
Leading Biology
ProSci
NSJ Bioreagents
OriGene Technologies
BioLegend
Bethyl Laboratories
ABclonal Technology
AssayPro
Miltenyi Biotec
Antigenix America Inc.
G Biosciences
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD74 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD74 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global CD74 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD74 Antibody Market Perspective (2020-2031)
2.2 Global CD74 Antibody Growth Trends by Region
2.2.1 Global CD74 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD74 Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD74 Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD74 Antibody Market Dynamics
2.3.1 CD74 Antibody Industry Trends
2.3.2 CD74 Antibody Market Drivers
2.3.3 CD74 Antibody Market Challenges
2.3.4 CD74 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD74 Antibody Players by Revenue
3.1.1 Global Top CD74 Antibody Players by Revenue (2020-2025)
3.1.2 Global CD74 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD74 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD74 Antibody Revenue
3.4 Global CD74 Antibody Market Concentration Ratio
3.4.1 Global CD74 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD74 Antibody Revenue in 2024
3.5 Global Key Players of CD74 Antibody Head office and Area Served
3.6 Global Key Players of CD74 Antibody, Product and Application
3.7 Global Key Players of CD74 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD74 Antibody Breakdown Data by Type
4.1 Global CD74 Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD74 Antibody Forecasted Market Size by Type (2026-2031)
5 CD74 Antibody Breakdown Data by Application
5.1 Global CD74 Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD74 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD74 Antibody Market Size (2020-2031)
6.2 North America CD74 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD74 Antibody Market Size by Country (2020-2025)
6.4 North America CD74 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD74 Antibody Market Size (2020-2031)
7.2 Europe CD74 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD74 Antibody Market Size by Country (2020-2025)
7.4 Europe CD74 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD74 Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD74 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD74 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD74 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD74 Antibody Market Size (2020-2031)
9.2 Latin America CD74 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD74 Antibody Market Size by Country (2020-2025)
9.4 Latin America CD74 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD74 Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD74 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD74 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD74 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck CD74 Antibody Introduction
11.1.4 Merck Revenue in CD74 Antibody Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Bioss
11.2.1 Bioss Company Details
11.2.2 Bioss Business Overview
11.2.3 Bioss CD74 Antibody Introduction
11.2.4 Bioss Revenue in CD74 Antibody Business (2020-2025)
11.2.5 Bioss Recent Development
11.3 BosterBio
11.3.1 BosterBio Company Details
11.3.2 BosterBio Business Overview
11.3.3 BosterBio CD74 Antibody Introduction
11.3.4 BosterBio Revenue in CD74 Antibody Business (2020-2025)
11.3.5 BosterBio Recent Development
11.4 QED Bioscience
11.4.1 QED Bioscience Company Details
11.4.2 QED Bioscience Business Overview
11.4.3 QED Bioscience CD74 Antibody Introduction
11.4.4 QED Bioscience Revenue in CD74 Antibody Business (2020-2025)
11.4.5 QED Bioscience Recent Development
11.5 Novus Biologicals
11.5.1 Novus Biologicals Company Details
11.5.2 Novus Biologicals Business Overview
11.5.3 Novus Biologicals CD74 Antibody Introduction
11.5.4 Novus Biologicals Revenue in CD74 Antibody Business (2020-2025)
11.5.5 Novus Biologicals Recent Development
11.6 GeneTex
11.6.1 GeneTex Company Details
11.6.2 GeneTex Business Overview
11.6.3 GeneTex CD74 Antibody Introduction
11.6.4 GeneTex Revenue in CD74 Antibody Business (2020-2025)
11.6.5 GeneTex Recent Development
11.7 RayBiotech
11.7.1 RayBiotech Company Details
11.7.2 RayBiotech Business Overview
11.7.3 RayBiotech CD74 Antibody Introduction
11.7.4 RayBiotech Revenue in CD74 Antibody Business (2020-2025)
11.7.5 RayBiotech Recent Development
11.8 LifeSpan BioSciences
11.8.1 LifeSpan BioSciences Company Details
11.8.2 LifeSpan BioSciences Business Overview
11.8.3 LifeSpan BioSciences CD74 Antibody Introduction
11.8.4 LifeSpan BioSciences Revenue in CD74 Antibody Business (2020-2025)
11.8.5 LifeSpan BioSciences Recent Development
11.9 EpiGentek
11.9.1 EpiGentek Company Details
11.9.2 EpiGentek Business Overview
11.9.3 EpiGentek CD74 Antibody Introduction
11.9.4 EpiGentek Revenue in CD74 Antibody Business (2020-2025)
11.9.5 EpiGentek Recent Development
11.10 Leading Biology
11.10.1 Leading Biology Company Details
11.10.2 Leading Biology Business Overview
11.10.3 Leading Biology CD74 Antibody Introduction
11.10.4 Leading Biology Revenue in CD74 Antibody Business (2020-2025)
11.10.5 Leading Biology Recent Development
11.11 ProSci
11.11.1 ProSci Company Details
11.11.2 ProSci Business Overview
11.11.3 ProSci CD74 Antibody Introduction
11.11.4 ProSci Revenue in CD74 Antibody Business (2020-2025)
11.11.5 ProSci Recent Development
11.12 NSJ Bioreagents
11.12.1 NSJ Bioreagents Company Details
11.12.2 NSJ Bioreagents Business Overview
11.12.3 NSJ Bioreagents CD74 Antibody Introduction
11.12.4 NSJ Bioreagents Revenue in CD74 Antibody Business (2020-2025)
11.12.5 NSJ Bioreagents Recent Development
11.13 OriGene Technologies
11.13.1 OriGene Technologies Company Details
11.13.2 OriGene Technologies Business Overview
11.13.3 OriGene Technologies CD74 Antibody Introduction
11.13.4 OriGene Technologies Revenue in CD74 Antibody Business (2020-2025)
11.13.5 OriGene Technologies Recent Development
11.14 BioLegend
11.14.1 BioLegend Company Details
11.14.2 BioLegend Business Overview
11.14.3 BioLegend CD74 Antibody Introduction
11.14.4 BioLegend Revenue in CD74 Antibody Business (2020-2025)
11.14.5 BioLegend Recent Development
11.15 Bethyl Laboratories
11.15.1 Bethyl Laboratories Company Details
11.15.2 Bethyl Laboratories Business Overview
11.15.3 Bethyl Laboratories CD74 Antibody Introduction
11.15.4 Bethyl Laboratories Revenue in CD74 Antibody Business (2020-2025)
11.15.5 Bethyl Laboratories Recent Development
11.16 ABclonal Technology
11.16.1 ABclonal Technology Company Details
11.16.2 ABclonal Technology Business Overview
11.16.3 ABclonal Technology CD74 Antibody Introduction
11.16.4 ABclonal Technology Revenue in CD74 Antibody Business (2020-2025)
11.16.5 ABclonal Technology Recent Development
11.17 AssayPro
11.17.1 AssayPro Company Details
11.17.2 AssayPro Business Overview
11.17.3 AssayPro CD74 Antibody Introduction
11.17.4 AssayPro Revenue in CD74 Antibody Business (2020-2025)
11.17.5 AssayPro Recent Development
11.18 Miltenyi Biotec
11.18.1 Miltenyi Biotec Company Details
11.18.2 Miltenyi Biotec Business Overview
11.18.3 Miltenyi Biotec CD74 Antibody Introduction
11.18.4 Miltenyi Biotec Revenue in CD74 Antibody Business (2020-2025)
11.18.5 Miltenyi Biotec Recent Development
11.19 Antigenix America Inc.
11.19.1 Antigenix America Inc. Company Details
11.19.2 Antigenix America Inc. Business Overview
11.19.3 Antigenix America Inc. CD74 Antibody Introduction
11.19.4 Antigenix America Inc. Revenue in CD74 Antibody Business (2020-2025)
11.19.5 Antigenix America Inc. Recent Development
11.20 G Biosciences
11.20.1 G Biosciences Company Details
11.20.2 G Biosciences Business Overview
11.20.3 G Biosciences CD74 Antibody Introduction
11.20.4 G Biosciences Revenue in CD74 Antibody Business (2020-2025)
11.20.5 G Biosciences Recent Development
11.21 Biobyt
11.21.1 Biobyt Company Details
11.21.2 Biobyt Business Overview
11.21.3 Biobyt CD74 Antibody Introduction
11.21.4 Biobyt Revenue in CD74 Antibody Business (2020-2025)
11.21.5 Biobyt Recent Development
11.22 Jingjie PTM BioLab
11.22.1 Jingjie PTM BioLab Company Details
11.22.2 Jingjie PTM BioLab Business Overview
11.22.3 Jingjie PTM BioLab CD74 Antibody Introduction
11.22.4 Jingjie PTM BioLab Revenue in CD74 Antibody Business (2020-2025)
11.22.5 Jingjie PTM BioLab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD74 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global CD74 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD74 Antibody Market Perspective (2020-2031)
2.2 Global CD74 Antibody Growth Trends by Region
2.2.1 Global CD74 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD74 Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD74 Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD74 Antibody Market Dynamics
2.3.1 CD74 Antibody Industry Trends
2.3.2 CD74 Antibody Market Drivers
2.3.3 CD74 Antibody Market Challenges
2.3.4 CD74 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD74 Antibody Players by Revenue
3.1.1 Global Top CD74 Antibody Players by Revenue (2020-2025)
3.1.2 Global CD74 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD74 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD74 Antibody Revenue
3.4 Global CD74 Antibody Market Concentration Ratio
3.4.1 Global CD74 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD74 Antibody Revenue in 2024
3.5 Global Key Players of CD74 Antibody Head office and Area Served
3.6 Global Key Players of CD74 Antibody, Product and Application
3.7 Global Key Players of CD74 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD74 Antibody Breakdown Data by Type
4.1 Global CD74 Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD74 Antibody Forecasted Market Size by Type (2026-2031)
5 CD74 Antibody Breakdown Data by Application
5.1 Global CD74 Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD74 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD74 Antibody Market Size (2020-2031)
6.2 North America CD74 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD74 Antibody Market Size by Country (2020-2025)
6.4 North America CD74 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD74 Antibody Market Size (2020-2031)
7.2 Europe CD74 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD74 Antibody Market Size by Country (2020-2025)
7.4 Europe CD74 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD74 Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD74 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD74 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD74 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD74 Antibody Market Size (2020-2031)
9.2 Latin America CD74 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD74 Antibody Market Size by Country (2020-2025)
9.4 Latin America CD74 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD74 Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD74 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD74 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD74 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck CD74 Antibody Introduction
11.1.4 Merck Revenue in CD74 Antibody Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Bioss
11.2.1 Bioss Company Details
11.2.2 Bioss Business Overview
11.2.3 Bioss CD74 Antibody Introduction
11.2.4 Bioss Revenue in CD74 Antibody Business (2020-2025)
11.2.5 Bioss Recent Development
11.3 BosterBio
11.3.1 BosterBio Company Details
11.3.2 BosterBio Business Overview
11.3.3 BosterBio CD74 Antibody Introduction
11.3.4 BosterBio Revenue in CD74 Antibody Business (2020-2025)
11.3.5 BosterBio Recent Development
11.4 QED Bioscience
11.4.1 QED Bioscience Company Details
11.4.2 QED Bioscience Business Overview
11.4.3 QED Bioscience CD74 Antibody Introduction
11.4.4 QED Bioscience Revenue in CD74 Antibody Business (2020-2025)
11.4.5 QED Bioscience Recent Development
11.5 Novus Biologicals
11.5.1 Novus Biologicals Company Details
11.5.2 Novus Biologicals Business Overview
11.5.3 Novus Biologicals CD74 Antibody Introduction
11.5.4 Novus Biologicals Revenue in CD74 Antibody Business (2020-2025)
11.5.5 Novus Biologicals Recent Development
11.6 GeneTex
11.6.1 GeneTex Company Details
11.6.2 GeneTex Business Overview
11.6.3 GeneTex CD74 Antibody Introduction
11.6.4 GeneTex Revenue in CD74 Antibody Business (2020-2025)
11.6.5 GeneTex Recent Development
11.7 RayBiotech
11.7.1 RayBiotech Company Details
11.7.2 RayBiotech Business Overview
11.7.3 RayBiotech CD74 Antibody Introduction
11.7.4 RayBiotech Revenue in CD74 Antibody Business (2020-2025)
11.7.5 RayBiotech Recent Development
11.8 LifeSpan BioSciences
11.8.1 LifeSpan BioSciences Company Details
11.8.2 LifeSpan BioSciences Business Overview
11.8.3 LifeSpan BioSciences CD74 Antibody Introduction
11.8.4 LifeSpan BioSciences Revenue in CD74 Antibody Business (2020-2025)
11.8.5 LifeSpan BioSciences Recent Development
11.9 EpiGentek
11.9.1 EpiGentek Company Details
11.9.2 EpiGentek Business Overview
11.9.3 EpiGentek CD74 Antibody Introduction
11.9.4 EpiGentek Revenue in CD74 Antibody Business (2020-2025)
11.9.5 EpiGentek Recent Development
11.10 Leading Biology
11.10.1 Leading Biology Company Details
11.10.2 Leading Biology Business Overview
11.10.3 Leading Biology CD74 Antibody Introduction
11.10.4 Leading Biology Revenue in CD74 Antibody Business (2020-2025)
11.10.5 Leading Biology Recent Development
11.11 ProSci
11.11.1 ProSci Company Details
11.11.2 ProSci Business Overview
11.11.3 ProSci CD74 Antibody Introduction
11.11.4 ProSci Revenue in CD74 Antibody Business (2020-2025)
11.11.5 ProSci Recent Development
11.12 NSJ Bioreagents
11.12.1 NSJ Bioreagents Company Details
11.12.2 NSJ Bioreagents Business Overview
11.12.3 NSJ Bioreagents CD74 Antibody Introduction
11.12.4 NSJ Bioreagents Revenue in CD74 Antibody Business (2020-2025)
11.12.5 NSJ Bioreagents Recent Development
11.13 OriGene Technologies
11.13.1 OriGene Technologies Company Details
11.13.2 OriGene Technologies Business Overview
11.13.3 OriGene Technologies CD74 Antibody Introduction
11.13.4 OriGene Technologies Revenue in CD74 Antibody Business (2020-2025)
11.13.5 OriGene Technologies Recent Development
11.14 BioLegend
11.14.1 BioLegend Company Details
11.14.2 BioLegend Business Overview
11.14.3 BioLegend CD74 Antibody Introduction
11.14.4 BioLegend Revenue in CD74 Antibody Business (2020-2025)
11.14.5 BioLegend Recent Development
11.15 Bethyl Laboratories
11.15.1 Bethyl Laboratories Company Details
11.15.2 Bethyl Laboratories Business Overview
11.15.3 Bethyl Laboratories CD74 Antibody Introduction
11.15.4 Bethyl Laboratories Revenue in CD74 Antibody Business (2020-2025)
11.15.5 Bethyl Laboratories Recent Development
11.16 ABclonal Technology
11.16.1 ABclonal Technology Company Details
11.16.2 ABclonal Technology Business Overview
11.16.3 ABclonal Technology CD74 Antibody Introduction
11.16.4 ABclonal Technology Revenue in CD74 Antibody Business (2020-2025)
11.16.5 ABclonal Technology Recent Development
11.17 AssayPro
11.17.1 AssayPro Company Details
11.17.2 AssayPro Business Overview
11.17.3 AssayPro CD74 Antibody Introduction
11.17.4 AssayPro Revenue in CD74 Antibody Business (2020-2025)
11.17.5 AssayPro Recent Development
11.18 Miltenyi Biotec
11.18.1 Miltenyi Biotec Company Details
11.18.2 Miltenyi Biotec Business Overview
11.18.3 Miltenyi Biotec CD74 Antibody Introduction
11.18.4 Miltenyi Biotec Revenue in CD74 Antibody Business (2020-2025)
11.18.5 Miltenyi Biotec Recent Development
11.19 Antigenix America Inc.
11.19.1 Antigenix America Inc. Company Details
11.19.2 Antigenix America Inc. Business Overview
11.19.3 Antigenix America Inc. CD74 Antibody Introduction
11.19.4 Antigenix America Inc. Revenue in CD74 Antibody Business (2020-2025)
11.19.5 Antigenix America Inc. Recent Development
11.20 G Biosciences
11.20.1 G Biosciences Company Details
11.20.2 G Biosciences Business Overview
11.20.3 G Biosciences CD74 Antibody Introduction
11.20.4 G Biosciences Revenue in CD74 Antibody Business (2020-2025)
11.20.5 G Biosciences Recent Development
11.21 Biobyt
11.21.1 Biobyt Company Details
11.21.2 Biobyt Business Overview
11.21.3 Biobyt CD74 Antibody Introduction
11.21.4 Biobyt Revenue in CD74 Antibody Business (2020-2025)
11.21.5 Biobyt Recent Development
11.22 Jingjie PTM BioLab
11.22.1 Jingjie PTM BioLab Company Details
11.22.2 Jingjie PTM BioLab Business Overview
11.22.3 Jingjie PTM BioLab CD74 Antibody Introduction
11.22.4 Jingjie PTM BioLab Revenue in CD74 Antibody Business (2020-2025)
11.22.5 Jingjie PTM BioLab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CD74 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global CD74 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global CD74 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CD74 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global CD74 Antibody Market Share by Region (2020-2025)
Table 8. Global CD74 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global CD74 Antibody Market Share by Region (2026-2031)
Table 10. CD74 Antibody Market Trends
Table 11. CD74 Antibody Market Drivers
Table 12. CD74 Antibody Market Challenges
Table 13. CD74 Antibody Market Restraints
Table 14. Global CD74 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global CD74 Antibody Market Share by Players (2020-2025)
Table 16. Global Top CD74 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD74 Antibody as of 2024)
Table 17. Ranking of Global Top CD74 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by CD74 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of CD74 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD74 Antibody, Product and Application
Table 21. Global Key Players of CD74 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD74 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global CD74 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global CD74 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global CD74 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global CD74 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global CD74 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global CD74 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global CD74 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America CD74 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America CD74 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America CD74 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe CD74 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe CD74 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe CD74 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific CD74 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific CD74 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific CD74 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD74 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America CD74 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America CD74 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa CD74 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa CD74 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa CD74 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Company Details
Table 47. Merck Business Overview
Table 48. Merck CD74 Antibody Product
Table 49. Merck Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Bioss Company Details
Table 52. Bioss Business Overview
Table 53. Bioss CD74 Antibody Product
Table 54. Bioss Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 55. Bioss Recent Development
Table 56. BosterBio Company Details
Table 57. BosterBio Business Overview
Table 58. BosterBio CD74 Antibody Product
Table 59. BosterBio Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 60. BosterBio Recent Development
Table 61. QED Bioscience Company Details
Table 62. QED Bioscience Business Overview
Table 63. QED Bioscience CD74 Antibody Product
Table 64. QED Bioscience Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 65. QED Bioscience Recent Development
Table 66. Novus Biologicals Company Details
Table 67. Novus Biologicals Business Overview
Table 68. Novus Biologicals CD74 Antibody Product
Table 69. Novus Biologicals Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 70. Novus Biologicals Recent Development
Table 71. GeneTex Company Details
Table 72. GeneTex Business Overview
Table 73. GeneTex CD74 Antibody Product
Table 74. GeneTex Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 75. GeneTex Recent Development
Table 76. RayBiotech Company Details
Table 77. RayBiotech Business Overview
Table 78. RayBiotech CD74 Antibody Product
Table 79. RayBiotech Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 80. RayBiotech Recent Development
Table 81. LifeSpan BioSciences Company Details
Table 82. LifeSpan BioSciences Business Overview
Table 83. LifeSpan BioSciences CD74 Antibody Product
Table 84. LifeSpan BioSciences Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 85. LifeSpan BioSciences Recent Development
Table 86. EpiGentek Company Details
Table 87. EpiGentek Business Overview
Table 88. EpiGentek CD74 Antibody Product
Table 89. EpiGentek Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 90. EpiGentek Recent Development
Table 91. Leading Biology Company Details
Table 92. Leading Biology Business Overview
Table 93. Leading Biology CD74 Antibody Product
Table 94. Leading Biology Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 95. Leading Biology Recent Development
Table 96. ProSci Company Details
Table 97. ProSci Business Overview
Table 98. ProSci CD74 Antibody Product
Table 99. ProSci Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 100. ProSci Recent Development
Table 101. NSJ Bioreagents Company Details
Table 102. NSJ Bioreagents Business Overview
Table 103. NSJ Bioreagents CD74 Antibody Product
Table 104. NSJ Bioreagents Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 105. NSJ Bioreagents Recent Development
Table 106. OriGene Technologies Company Details
Table 107. OriGene Technologies Business Overview
Table 108. OriGene Technologies CD74 Antibody Product
Table 109. OriGene Technologies Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 110. OriGene Technologies Recent Development
Table 111. BioLegend Company Details
Table 112. BioLegend Business Overview
Table 113. BioLegend CD74 Antibody Product
Table 114. BioLegend Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 115. BioLegend Recent Development
Table 116. Bethyl Laboratories Company Details
Table 117. Bethyl Laboratories Business Overview
Table 118. Bethyl Laboratories CD74 Antibody Product
Table 119. Bethyl Laboratories Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 120. Bethyl Laboratories Recent Development
Table 121. ABclonal Technology Company Details
Table 122. ABclonal Technology Business Overview
Table 123. ABclonal Technology CD74 Antibody Product
Table 124. ABclonal Technology Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 125. ABclonal Technology Recent Development
Table 126. AssayPro Company Details
Table 127. AssayPro Business Overview
Table 128. AssayPro CD74 Antibody Product
Table 129. AssayPro Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 130. AssayPro Recent Development
Table 131. Miltenyi Biotec Company Details
Table 132. Miltenyi Biotec Business Overview
Table 133. Miltenyi Biotec CD74 Antibody Product
Table 134. Miltenyi Biotec Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 135. Miltenyi Biotec Recent Development
Table 136. Antigenix America Inc. Company Details
Table 137. Antigenix America Inc. Business Overview
Table 138. Antigenix America Inc. CD74 Antibody Product
Table 139. Antigenix America Inc. Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 140. Antigenix America Inc. Recent Development
Table 141. G Biosciences Company Details
Table 142. G Biosciences Business Overview
Table 143. G Biosciences CD74 Antibody Product
Table 144. G Biosciences Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 145. G Biosciences Recent Development
Table 146. Biobyt Company Details
Table 147. Biobyt Business Overview
Table 148. Biobyt CD74 Antibody Product
Table 149. Biobyt Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 150. Biobyt Recent Development
Table 151. Jingjie PTM BioLab Company Details
Table 152. Jingjie PTM BioLab Business Overview
Table 153. Jingjie PTM BioLab CD74 Antibody Product
Table 154. Jingjie PTM BioLab Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 155. Jingjie PTM BioLab Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report
List of Figures
Figure 1. CD74 Antibody Picture
Figure 2. Global CD74 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD74 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global CD74 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global CD74 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. CD74 Antibody Report Years Considered
Figure 15. Global CD74 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CD74 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CD74 Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global CD74 Antibody Market Share by Players in 2024
Figure 19. Global Top CD74 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD74 Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CD74 Antibody Revenue in 2024
Figure 21. North America CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CD74 Antibody Market Share by Country (2020-2031)
Figure 23. United States CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CD74 Antibody Market Share by Country (2020-2031)
Figure 27. Germany CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CD74 Antibody Market Share by Region (2020-2031)
Figure 35. China CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CD74 Antibody Market Share by Country (2020-2031)
Figure 43. Mexico CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CD74 Antibody Market Share by Country (2020-2031)
Figure 47. Turkey CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 51. Bioss Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 52. BosterBio Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 53. QED Bioscience Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 54. Novus Biologicals Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 55. GeneTex Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 56. RayBiotech Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 57. LifeSpan BioSciences Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 58. EpiGentek Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 59. Leading Biology Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 60. ProSci Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 61. NSJ Bioreagents Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 62. OriGene Technologies Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 63. BioLegend Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 64. Bethyl Laboratories Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 65. ABclonal Technology Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 66. AssayPro Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 67. Miltenyi Biotec Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 68. Antigenix America Inc. Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 69. G Biosciences Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 70. Biobyt Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 71. Jingjie PTM BioLab Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Table 1. Global CD74 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global CD74 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global CD74 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CD74 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global CD74 Antibody Market Share by Region (2020-2025)
Table 8. Global CD74 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global CD74 Antibody Market Share by Region (2026-2031)
Table 10. CD74 Antibody Market Trends
Table 11. CD74 Antibody Market Drivers
Table 12. CD74 Antibody Market Challenges
Table 13. CD74 Antibody Market Restraints
Table 14. Global CD74 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global CD74 Antibody Market Share by Players (2020-2025)
Table 16. Global Top CD74 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD74 Antibody as of 2024)
Table 17. Ranking of Global Top CD74 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by CD74 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of CD74 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD74 Antibody, Product and Application
Table 21. Global Key Players of CD74 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD74 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global CD74 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global CD74 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global CD74 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global CD74 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global CD74 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global CD74 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global CD74 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America CD74 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America CD74 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America CD74 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe CD74 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe CD74 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe CD74 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific CD74 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific CD74 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific CD74 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD74 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America CD74 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America CD74 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa CD74 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa CD74 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa CD74 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Company Details
Table 47. Merck Business Overview
Table 48. Merck CD74 Antibody Product
Table 49. Merck Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Bioss Company Details
Table 52. Bioss Business Overview
Table 53. Bioss CD74 Antibody Product
Table 54. Bioss Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 55. Bioss Recent Development
Table 56. BosterBio Company Details
Table 57. BosterBio Business Overview
Table 58. BosterBio CD74 Antibody Product
Table 59. BosterBio Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 60. BosterBio Recent Development
Table 61. QED Bioscience Company Details
Table 62. QED Bioscience Business Overview
Table 63. QED Bioscience CD74 Antibody Product
Table 64. QED Bioscience Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 65. QED Bioscience Recent Development
Table 66. Novus Biologicals Company Details
Table 67. Novus Biologicals Business Overview
Table 68. Novus Biologicals CD74 Antibody Product
Table 69. Novus Biologicals Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 70. Novus Biologicals Recent Development
Table 71. GeneTex Company Details
Table 72. GeneTex Business Overview
Table 73. GeneTex CD74 Antibody Product
Table 74. GeneTex Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 75. GeneTex Recent Development
Table 76. RayBiotech Company Details
Table 77. RayBiotech Business Overview
Table 78. RayBiotech CD74 Antibody Product
Table 79. RayBiotech Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 80. RayBiotech Recent Development
Table 81. LifeSpan BioSciences Company Details
Table 82. LifeSpan BioSciences Business Overview
Table 83. LifeSpan BioSciences CD74 Antibody Product
Table 84. LifeSpan BioSciences Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 85. LifeSpan BioSciences Recent Development
Table 86. EpiGentek Company Details
Table 87. EpiGentek Business Overview
Table 88. EpiGentek CD74 Antibody Product
Table 89. EpiGentek Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 90. EpiGentek Recent Development
Table 91. Leading Biology Company Details
Table 92. Leading Biology Business Overview
Table 93. Leading Biology CD74 Antibody Product
Table 94. Leading Biology Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 95. Leading Biology Recent Development
Table 96. ProSci Company Details
Table 97. ProSci Business Overview
Table 98. ProSci CD74 Antibody Product
Table 99. ProSci Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 100. ProSci Recent Development
Table 101. NSJ Bioreagents Company Details
Table 102. NSJ Bioreagents Business Overview
Table 103. NSJ Bioreagents CD74 Antibody Product
Table 104. NSJ Bioreagents Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 105. NSJ Bioreagents Recent Development
Table 106. OriGene Technologies Company Details
Table 107. OriGene Technologies Business Overview
Table 108. OriGene Technologies CD74 Antibody Product
Table 109. OriGene Technologies Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 110. OriGene Technologies Recent Development
Table 111. BioLegend Company Details
Table 112. BioLegend Business Overview
Table 113. BioLegend CD74 Antibody Product
Table 114. BioLegend Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 115. BioLegend Recent Development
Table 116. Bethyl Laboratories Company Details
Table 117. Bethyl Laboratories Business Overview
Table 118. Bethyl Laboratories CD74 Antibody Product
Table 119. Bethyl Laboratories Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 120. Bethyl Laboratories Recent Development
Table 121. ABclonal Technology Company Details
Table 122. ABclonal Technology Business Overview
Table 123. ABclonal Technology CD74 Antibody Product
Table 124. ABclonal Technology Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 125. ABclonal Technology Recent Development
Table 126. AssayPro Company Details
Table 127. AssayPro Business Overview
Table 128. AssayPro CD74 Antibody Product
Table 129. AssayPro Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 130. AssayPro Recent Development
Table 131. Miltenyi Biotec Company Details
Table 132. Miltenyi Biotec Business Overview
Table 133. Miltenyi Biotec CD74 Antibody Product
Table 134. Miltenyi Biotec Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 135. Miltenyi Biotec Recent Development
Table 136. Antigenix America Inc. Company Details
Table 137. Antigenix America Inc. Business Overview
Table 138. Antigenix America Inc. CD74 Antibody Product
Table 139. Antigenix America Inc. Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 140. Antigenix America Inc. Recent Development
Table 141. G Biosciences Company Details
Table 142. G Biosciences Business Overview
Table 143. G Biosciences CD74 Antibody Product
Table 144. G Biosciences Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 145. G Biosciences Recent Development
Table 146. Biobyt Company Details
Table 147. Biobyt Business Overview
Table 148. Biobyt CD74 Antibody Product
Table 149. Biobyt Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 150. Biobyt Recent Development
Table 151. Jingjie PTM BioLab Company Details
Table 152. Jingjie PTM BioLab Business Overview
Table 153. Jingjie PTM BioLab CD74 Antibody Product
Table 154. Jingjie PTM BioLab Revenue in CD74 Antibody Business (2020-2025) & (US$ Million)
Table 155. Jingjie PTM BioLab Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report
List of Figures
Figure 1. CD74 Antibody Picture
Figure 2. Global CD74 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD74 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global CD74 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global CD74 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. CD74 Antibody Report Years Considered
Figure 15. Global CD74 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CD74 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CD74 Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global CD74 Antibody Market Share by Players in 2024
Figure 19. Global Top CD74 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD74 Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CD74 Antibody Revenue in 2024
Figure 21. North America CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CD74 Antibody Market Share by Country (2020-2031)
Figure 23. United States CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CD74 Antibody Market Share by Country (2020-2031)
Figure 27. Germany CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CD74 Antibody Market Share by Region (2020-2031)
Figure 35. China CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CD74 Antibody Market Share by Country (2020-2031)
Figure 43. Mexico CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CD74 Antibody Market Share by Country (2020-2031)
Figure 47. Turkey CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CD74 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 51. Bioss Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 52. BosterBio Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 53. QED Bioscience Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 54. Novus Biologicals Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 55. GeneTex Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 56. RayBiotech Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 57. LifeSpan BioSciences Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 58. EpiGentek Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 59. Leading Biology Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 60. ProSci Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 61. NSJ Bioreagents Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 62. OriGene Technologies Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 63. BioLegend Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 64. Bethyl Laboratories Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 65. ABclonal Technology Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 66. AssayPro Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 67. Miltenyi Biotec Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 68. Antigenix America Inc. Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 69. G Biosciences Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 70. Biobyt Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 71. Jingjie PTM BioLab Revenue Growth Rate in CD74 Antibody Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232